首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   105篇
  免费   2篇
  2008年   2篇
  2007年   2篇
  2002年   3篇
  2001年   3篇
  2000年   3篇
  1994年   1篇
  1993年   1篇
  1992年   4篇
  1991年   1篇
  1990年   2篇
  1989年   5篇
  1988年   1篇
  1987年   1篇
  1985年   1篇
  1981年   1篇
  1977年   1篇
  1975年   3篇
  1974年   1篇
  1973年   2篇
  1972年   3篇
  1971年   6篇
  1970年   3篇
  1969年   2篇
  1968年   1篇
  1967年   3篇
  1966年   1篇
  1964年   2篇
  1962年   4篇
  1958年   2篇
  1957年   3篇
  1956年   1篇
  1955年   3篇
  1954年   1篇
  1953年   1篇
  1952年   1篇
  1951年   1篇
  1948年   1篇
  1943年   5篇
  1942年   1篇
  1940年   1篇
  1939年   1篇
  1938年   1篇
  1937年   2篇
  1935年   2篇
  1934年   1篇
  1933年   1篇
  1931年   1篇
  1930年   2篇
  1929年   2篇
  1927年   1篇
排序方式: 共有107条查询结果,搜索用时 109 毫秒
1.
Zusammenfassung Der Nachweis wird erbracht, daß in manchen Früchten und Samen die typischen mikroskopischen Bodenpilze vorhanden sind. Auf das Wechselspiel zwischen Korn und Pilz wird, unter Berücksichtigung des Problems der Wuchs-und der Hemmungsstoffe, eingegangen.  相似文献   
2.
    
Ohne Zusammenfassung  相似文献   
3.
4.
5.
Zusammenfassung Quecksilberverbindungen schädigen im allgemeinen die Zelle weniger, als man glaubt. Diese Tatsache ist durch das geringe Permeierungsvermögen dieser Verbindungen bedingt. Echte Plasmolyse kann man mit ihnen nicht erzielen.  相似文献   
6.
7.
Between 1982 and 1986 51 patients were treated with ciclosporin a (CSA) to prevent graft versus host disease (GvHD) after bone marrow transplantation (BMT). Major side effects of the drug were tremor, hypertension, hepatotoxicity and nephrotoxicity. Acute GvHD 0 degree to II degree occurred in 80% of our patients, and GvHD III degree and IV degree in 20% despite the use of CSA. Two to four days before the onset of GvHD, CSA serum levels were significantly lower on the average in patients who developed GvHD III degree and IV degree compared to the others. Our data indicate that plasma CSA concentrations higher than 250 ng/ml should be achieved to reduce the severity of GvHD after BMT.  相似文献   
8.
Correlative microscopy is a sophisticated approach that combines the capabilities of typically separate, but powerful microscopy platforms: often including, but not limited, to conventional light, confocal and super-resolution microscopy, atomic force microscopy, transmission and scanning electron microscopy, magnetic resonance imaging and micro/nano CT (computed tomography). When targeting rare or specific events within large populations or tissues, correlative microscopy is increasingly being recognized as the method of choice. Furthermore, this multi-modal assimilation of technologies provides complementary and often unique information, such as internal and external spatial, structural, biochemical and biophysical details from the same targeted sample. The development of a continuous stream of cutting-edge applications, probes, preparation methodologies, hardware and software developments will enable realization of the full potential of correlative microscopy.  相似文献   
9.
The development of novel chemotherapy strategies based on prodrugs remains a major challenge for effective treatment of malignancies. We tested the hypothesis that this can be achieved by a prodrug of paclitaxel where one biologically active center, represented by the C7 hydroxyl group, was blocked by a dihydroxypropyl side chain which can be hydrolytically cleaved by a pH-dependent, slow-release mechanism. The prodrug was synthesized by condensation of solketal chloroformate with the C7 hydroxyl group of paclitaxel followed by a ring-opening reaction to the dihydroxyl derivative. The cytotoxicity of the prodrug was similar to paclitaxel, when tested in vitro against a variety of human tumor cell lines. In vitro cell cycle analysis indicated that concentrations within the micromolar range of both drug and prodrug are required to induce sufficient G2M arrest. The hydrophilic paclitaxel prodrug proved to be more than 50-fold more water soluble than the parental drug and effectively converted to paclitaxel by pH dependent hydrolysis. Importantly, the prodrug could be used at a 3-fold higher maximum tolerated dose (MTD) and revealed a markedly improved antitumor activity in mice compared to paclitaxel. Taken together, our results demonstrate, that a hydrolytically activated paclitaxel prodrug exhibits greater water solubility and superior antitumor activity than the parental drug.  相似文献   
10.
Determinants of antileukemia effects of allogeneic NK cells   总被引:25,自引:0,他引:25  
In HLA-nonidentical bone marrow transplantation, we studied the characteristics of donor NK cells, recipient leukemia cells, and the cytokine environment that predict the antileukemia effects of allogeneic NK cells. We found that the risk of relapse in pediatric patients with hematologic malignancies was best predicted by a model taking into consideration the presence of inhibitory killer cell Ig-like receptors (KIRs) on the donor's NK cells and the absence of corresponding KIR ligand in the recipient's HLA repertoire (a receptor-ligand model). The risk of relapse was prognosticated less precisely by the Perugia donor-recipient KIR ligand-ligand mismatch model or by a natural cytotoxicity model. In contrast to the ligand-ligand model, we found that the new receptor-ligand model was accurate when analysis was applied to patients with lymphoid malignancy. These findings corroborate our observations that the recipient's KIR repertoire, which was derived from highly purified, HLA-disparate CD34+ cells, resumed a donor-specific pattern within 3 mo of transplantation, but did not correlate evidently with the donor or recipient ligand repertoire. In an in vitro assay and an in vivo mouse model, human NK cell cytotoxicity toward human leukemia cells with 11q23 chromosomal rearrangement increased with the number of receptor-ligand mismatch pairs or prestimulation with IL-12 and IL-18. These findings provide new insights into the determinants of antileukemia effects of allogeneic NK cells and therapeutic strategies.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号